NDM metallo-β-lactamases and their bacterial producers in health care settings

W Wu, Y Feng, G Tang, F Qiao… - Clinical microbiology …, 2019 - Am Soc Microbiol
New Delhi metallo-β-lactamase (NDM) is a metallo-β-lactamase able to hydrolyze almost all
β-lactams. Twenty-four NDM variants have been identified in> 60 species of 11 bacterial …

Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes

L Poirel, A Jayol, P Nordmann - Clinical microbiology reviews, 2017 - Am Soc Microbiol
Polymyxins are well-established antibiotics that have recently regained significant interest
as a consequence of the increasing incidence of infections due to multidrug-resistant Gram …

History of antimicrobial drug discovery: Major classes and health impact

R Aminov - Biochemical pharmacology, 2017 - Elsevier
The introduction of antibiotics into clinical practice revolutionized the treatment and
management of infectious diseases. Before the introduction of antibiotics, these diseases …

Agents of last resort: polymyxin resistance

KS Kaye, JM Pogue, TB Tran, RL Nation… - Infectious Disease …, 2016 - id.theclinics.com
The polymyxins, colistin (also known as polymyxin E) and polymyxin B, have a unique and
interesting history. Originally introduced in the 1950s for the treatment of infections due to …

Antimicrobial susceptibility testing for polymyxins: challenges, issues, and recommendations

F Ezadi, A Ardebili, R Mirnejad - Journal of clinical microbiology, 2019 - Am Soc Microbiol
Polymyxins, including polymyxin B and polymyxin E (colistin), are now increasingly being
used worldwide to treat patients with multidrug-resistant (MDR) Gram-negative bacterial …

Polymyxin-induced nephrotoxicity and its predictors: a systematic review and meta-analysis of studies conducted using RIFLE criteria of acute kidney injury

M Sisay, B Hagos, D Edessa, Y Tadiwos… - Pharmacological …, 2021 - Elsevier
Polymyxins are last-resort antibiotics re-emerged to treat infections caused by multidrug
resistant (MDR) and extensively drug-resistant (XDR) Gram-negative bacterial infections …

Antimicrobial peptides

DE Fry - Surgical infections, 2018 - liebertpub.com
Background: Bacterial resistance to available antibiotics has resulted in enhanced efforts at
antibiotic stewardship but also has led to investigation into alternative methods for managing …

Therapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward ' …

NG El Chakhtoura, E Saade, A Iovleva… - Expert review of anti …, 2018 - Taylor & Francis
ABSTRACT Introduction: Non-fermenting Gram-negative bacilli are at the center of the
antimicrobial resistance epidemic. Acinetobacter baumannii and Pseudomonas aeruginosa …

Colistin for the treatment of urinary tract infections caused by extremely drug-resistant Pseudomonas aeruginosa: dose is critical

L Sorlí, S Luque, J Li, N Campillo, M Danés… - Journal of Infection, 2019 - Elsevier
Objectives Optimal dosage regimens of colistin for the treatment of urinary tract infections
(UTI) are unknown. Colistimethate sodium (CMS), the inactive prodrug of colistin, is mainly …

[HTML][HTML] Clinical considerations for optimal use of the polymyxins: a focus on agent selection and dosing

JM Pogue, JK Ortwine, KS Kaye - Clinical Microbiology and Infection, 2017 - Elsevier
Polymyxins have remained the drug of choice for treatment due to carbapenem-resistant
Gram-negative bacilli. Unfortunately, the utility of these agents has been limited by a lack of …